Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032554238> ?p ?o ?g. }
- W3032554238 abstract "Abstract The antiandrogen enzalutamide (Enz) has improved survival in castration resistant prostate cancer (CRPC) patients. However, most patients eventually develop Enz resistance that may involve inducing the androgen receptor (AR) splicing variant 7 (ARv7). Here we report that high expression of monoamine oxidase-A (MAO-A) is associated with positive ARv7 detection in CRPC patients following Enz treatment. Targeting MAO-A with phenelzine or clorgyline, the FDA-approved drugs for antidepression, resensitize the Enz resistant (EnzR) cells to Enz treatment and further suppress EnzR cell growth in vitro and in vivo. Our findings suggest that Enz-increased ARv7 expression can transcriptionally enhance MAO-A expression resulting in Enz resistance via altering the hypoxia HIF-1α signals. Together, our results show that targeting the Enz/ARv7/MAO-A signaling with the antidepressants phenelzine or clorgyline can restore Enz sensitivity to suppress EnzR cell growth, which may indicate that these antidepression drugs can overcome the Enz resistance to further suppress the EnzR CRPC." @default.
- W3032554238 created "2020-06-05" @default.
- W3032554238 creator A5005278584 @default.
- W3032554238 creator A5011559773 @default.
- W3032554238 creator A5016060924 @default.
- W3032554238 creator A5021089842 @default.
- W3032554238 creator A5022666245 @default.
- W3032554238 creator A5022808702 @default.
- W3032554238 creator A5024338553 @default.
- W3032554238 creator A5024770488 @default.
- W3032554238 creator A5026456311 @default.
- W3032554238 creator A5041721692 @default.
- W3032554238 creator A5054029858 @default.
- W3032554238 creator A5057048206 @default.
- W3032554238 creator A5064286400 @default.
- W3032554238 creator A5075880342 @default.
- W3032554238 creator A5077552075 @default.
- W3032554238 date "2020-06-01" @default.
- W3032554238 modified "2023-10-15" @default.
- W3032554238 title "The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer" @default.
- W3032554238 cites W1510118021 @default.
- W3032554238 cites W1534417549 @default.
- W3032554238 cites W1534849470 @default.
- W3032554238 cites W1882606371 @default.
- W3032554238 cites W1970314228 @default.
- W3032554238 cites W1979859269 @default.
- W3032554238 cites W2000158828 @default.
- W3032554238 cites W2003574643 @default.
- W3032554238 cites W2007334137 @default.
- W3032554238 cites W2007477027 @default.
- W3032554238 cites W2010072924 @default.
- W3032554238 cites W2010516785 @default.
- W3032554238 cites W2014970890 @default.
- W3032554238 cites W2017919614 @default.
- W3032554238 cites W2022825762 @default.
- W3032554238 cites W2025221196 @default.
- W3032554238 cites W2035637535 @default.
- W3032554238 cites W2049935617 @default.
- W3032554238 cites W2080748037 @default.
- W3032554238 cites W2081717002 @default.
- W3032554238 cites W2085847636 @default.
- W3032554238 cites W2093585033 @default.
- W3032554238 cites W2097226696 @default.
- W3032554238 cites W2100252302 @default.
- W3032554238 cites W2107151134 @default.
- W3032554238 cites W2108914747 @default.
- W3032554238 cites W2110841612 @default.
- W3032554238 cites W2121846636 @default.
- W3032554238 cites W2130189600 @default.
- W3032554238 cites W2132850027 @default.
- W3032554238 cites W2139173424 @default.
- W3032554238 cites W2140675573 @default.
- W3032554238 cites W2149131962 @default.
- W3032554238 cites W2149472336 @default.
- W3032554238 cites W2155252516 @default.
- W3032554238 cites W2156923287 @default.
- W3032554238 cites W2162175064 @default.
- W3032554238 cites W2166324735 @default.
- W3032554238 cites W2168611833 @default.
- W3032554238 cites W2171429997 @default.
- W3032554238 cites W2222964038 @default.
- W3032554238 cites W2290606825 @default.
- W3032554238 cites W2313395976 @default.
- W3032554238 cites W2595857857 @default.
- W3032554238 cites W2604800509 @default.
- W3032554238 cites W2616577186 @default.
- W3032554238 cites W2806710458 @default.
- W3032554238 cites W2807716198 @default.
- W3032554238 cites W2950536598 @default.
- W3032554238 cites W4211024301 @default.
- W3032554238 cites W4232547688 @default.
- W3032554238 doi "https://doi.org/10.1038/s41467-020-15396-5" @default.
- W3032554238 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7264333" @default.
- W3032554238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32483206" @default.
- W3032554238 hasPublicationYear "2020" @default.
- W3032554238 type Work @default.
- W3032554238 sameAs 3032554238 @default.
- W3032554238 citedByCount "36" @default.
- W3032554238 countsByYear W30325542382020 @default.
- W3032554238 countsByYear W30325542382021 @default.
- W3032554238 countsByYear W30325542382022 @default.
- W3032554238 countsByYear W30325542382023 @default.
- W3032554238 crossrefType "journal-article" @default.
- W3032554238 hasAuthorship W3032554238A5005278584 @default.
- W3032554238 hasAuthorship W3032554238A5011559773 @default.
- W3032554238 hasAuthorship W3032554238A5016060924 @default.
- W3032554238 hasAuthorship W3032554238A5021089842 @default.
- W3032554238 hasAuthorship W3032554238A5022666245 @default.
- W3032554238 hasAuthorship W3032554238A5022808702 @default.
- W3032554238 hasAuthorship W3032554238A5024338553 @default.
- W3032554238 hasAuthorship W3032554238A5024770488 @default.
- W3032554238 hasAuthorship W3032554238A5026456311 @default.
- W3032554238 hasAuthorship W3032554238A5041721692 @default.
- W3032554238 hasAuthorship W3032554238A5054029858 @default.
- W3032554238 hasAuthorship W3032554238A5057048206 @default.
- W3032554238 hasAuthorship W3032554238A5064286400 @default.
- W3032554238 hasAuthorship W3032554238A5075880342 @default.
- W3032554238 hasAuthorship W3032554238A5077552075 @default.
- W3032554238 hasBestOaLocation W30325542381 @default.
- W3032554238 hasConcept C121608353 @default.